About us

Our Team



Didier has 30 years’ experience in drug delivery using colloids, ranging from basic research to clinical trials. He has collaborated with BioChem Pharma, GSK, Sanofi Pasteur and Chiron-Novartis on the evaluation of nasal vaccine using nanotechnologies. As an international expert in nanomedicine, he presided at the French Society for Controlled Release, was a board member of the French Society of Nanomedicine, and has over 110 international publications and 23 patents.

After a PhD on drug targeting in collaboration with the World Health Organization, Didier developed a patented technology for vaccine applications based on polysaccharidic nanoparticles with a phospholipid bi-layer.

His experience, innovative research and patented technology are at the heart of Vaxinano.